<DOC>
	<DOCNO>NCT01069601</DOCNO>
	<brief_summary>The trial investigate efficacy adjuvanted H1N1 influenza vaccine Focetria ( R ) immunocompromised adult undergone solid organ bone marrow transplantation . It expect administered twice vaccine fulfills serological efficacy criterion require elderly population age 60 year old .</brief_summary>
	<brief_title>H1N1sw Vaccine Adult Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Adult subject 1860 year age undergone prior renal , cardiac , liver , lung , bone marrow transplantation reason , 3 month prior enrolment Patients able visit outpatient clinic life expectancy least one year Patients receive immunosuppressive treatment currently take prevent organ rejection Individuals receive vaccine within 30 day prior study entry Individuals receive H1N1 vaccination le 6 month prior study Influenza diagnose physician within 4 month prior study start Pregnant lactating female History anaphylactic ( i.e . lifethreatening ) reaction component vaccine , include egg chicken protein , ovalbumin , kanamycin neomycin sulphate , formaldehyde cetyltrimethylammonium bromide ( CTAB )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>solid organ transplantation</keyword>
	<keyword>bone marrow transplantation</keyword>
	<keyword>adult</keyword>
	<keyword>adult solid organ transplantation</keyword>
	<keyword>adult bone marrow transplantation</keyword>
</DOC>